Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
about
Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.Quantum Dot-Based Nanotools for Bioimaging, Diagnostics, and Drug Delivery.Formation of targeted monovalent quantum dots by steric exclusion.Heterobifunctional PEG ligands for bioconjugation reactions on iron oxide nanoparticles.Conjugation of Polymer-Coated Gold Nanoparticles with Antibodies-Synthesis and Characterization.Antibody fragments as nanoparticle targeting ligands: a step in the right directionNanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona FormationTumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies.Functionalization of protein-based nanocages for drug delivery applications.Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.In vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far?Shape matters: synthesis and biomedical applications of high aspect ratio magnetic nanomaterials.Biocompatible Size-Defined Dendrimer-Albumin Binding Protein Hybrid Materials as a Versatile Platform for Biomedical Applications.Antibody-targeted nanoparticles for cancer treatment.Multi-Functionalized Carbon Nano-onions as Imaging Probes for Cancer Cells.Gold nanoparticle-based localized surface plasmon immunosensor for staphylococcal enterotoxin A (SEA) detection.Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity.Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles.Tunability of Size and Magnetic Moment of Iron Oxide Nanoparticles Synthesized by Forced Hydrolysis.Behavior of ligand binding assays with crowded surfaces: Molecular model of antigen capture by antibody-conjugated nanoparticles.Covalent Protein Labeling and Improved Single-Molecule Optical Properties of Aqueous CdSe/CdS Quantum Dots.Chemical modification of antibodies enables the formation of stable antibody-gold nanoparticle conjugates for biosensing.Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation.A Functional CT Contrast Agent for In Vivo Imaging of Tumor Hypoxia.Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.En route to traceable reference standards for surface group quantifications by XPS, NMR and fluorescence spectroscopy.“To Catch or Not to Catch”: Microcapsule-Based Sandwich Assay for Detection of Proteins and Nucleic AcidsRare-Earth-Doped Nanoparticles for Short-Wave Infrared Fluorescence Bioimaging and Molecular Targeting of αβ-Expressing Tumors
P2860
Q31004643-AF2CA5E8-79EE-4BB6-AB64-4B9A4A81A81DQ31122176-1D94A1E2-DA9C-4FC5-885E-E0374CEDE8DDQ34377471-75517A5F-6896-4742-94CE-608FCB6DFF2FQ35294216-05C3B82E-BB90-440B-A58C-99FE2744A358Q36324205-E6E99866-9378-40F9-82A8-AA4DFA1558A8Q36357291-EF0A9B4F-C32B-4F12-8218-B3C26F4CBB64Q36461811-5A35623B-7BDD-40EB-9A56-3F636F10D181Q36828184-8FFFA917-8079-4467-B586-1F0C6E480C6DQ37533321-2383D43F-F128-4B43-B05C-A250AFCF6C2DQ38214775-E24B3D00-0875-45EF-8B20-814AD6109BAAQ38235410-EED25F7D-0443-4828-8A24-AB0FDD48059CQ38253370-5289BB6F-B561-4C52-9B4A-CACC2D949BDDQ38422536-E1AE99F0-7CCC-40EF-9FB0-095396E1776BQ38805312-3797B9CB-EC2D-413C-B07C-2555854688EBQ38887307-D477E9D1-25F9-40A9-878C-BEC5B79AC17EQ38941896-2F706AD5-C54D-4C4A-9458-25F41F55ABDEQ41596784-9FB39026-EEAA-4921-B711-38CC3B68C303Q41606644-23129961-0042-4387-9825-E5A9901A3680Q41962637-4571BBA2-3FC5-4F45-9C59-D9E65B93613BQ42225549-BC185A77-27DC-4812-A4F8-DCD88EAFC9F2Q42366239-B436DB01-CBEB-4815-BBF6-3209B0BADCEAQ46264138-95F1584A-0A59-435B-91BF-28D02C3A4A60Q47594023-48A8DED5-6F69-47C2-A12A-3EC64DD1689CQ47725919-A110BFD3-EF7F-4199-BB61-BD9E77ED4EF3Q50697137-9A45A699-901E-470A-8E0F-44140A430065Q51501435-939EEFA9-C806-4D24-BDBD-7AB2950AD7DAQ52716381-376C0888-A7E8-4B8F-8E2F-BF4BCE354732Q52869994-1E11FEA9-D810-4424-BBC6-E1FAEF2B24DDQ57816707-B5C78484-40AB-4F66-A09A-FBA0671E68A5Q58701225-E8319A81-F79B-40A2-A24C-5B7CD6CCA74A
P2860
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
@en
type
label
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
@en
prefLabel
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
@en
P2093
P50
P1476
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
@en
P2093
Andreas Greiner
Jose-Maria Montenegro
Seema Agarwal
Valeria Grazu
Wolfgang J Parak
P304
P356
10.1016/J.ADDR.2012.12.003
P407
P577
2012-12-29T00:00:00Z